Its observed effect on MMP-2, can be of particular relevance in the context of melanoma, notorious for its highly aggressive and angiogenic nature, with ten-year survival rates as low as 10-15% in cases of advanced stage tumors [20]. This evidence concerns the gene MMP2 and melanoma.